[Analysis of fatality rates case of SARS-CoV-2 infection in the Autonomous Communities of Spain].
Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España.
Autonomous communities
Comunidades autónomas
España
SARS-CoV-2
Spain
Journal
Semergen
ISSN: 1578-8865
Titre abrégé: Semergen
Pays: Spain
ID NLM: 9610769
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
15
06
2020
revised:
22
06
2020
accepted:
23
06
2020
pubmed:
28
7
2020
medline:
28
8
2020
entrez:
26
7
2020
Statut:
ppublish
Résumé
The SARS-CoV-2 pandemic has posed a real challenge to health systems. In Spain, the heterogeneous distribution of the virus infection and the different health strategies have conditioned the morbidity and fatality rate. The aim of this study was to analyse the lethality of the infection by sex and age range in the Autonomous Communities (AC) of Spain. To perform the analysis, data were extracted from the Ministry of Health, Regional and Public Health Departments of the different AC. The infected population was estimated from the results of the ENE-COVID19 and the population registered on 1 January 2020 (INE) for the validity of the IgG antibody test with 80% sensitivity and 100% specificity. The case fatality rate (TL) (deaths/1000 estimated infected) by sex and age (<20years, 20-64 and ≥65years) was calculated for each AC. The standardized case fatality ratio (REL) was calculated by the exact method (EPIDAT). The estimated prevalence of SARS-CoV-2 infection in Spain was 6% (range, 1.4% [Ceuta] -14.1% [Community of Madrid]). The TL in Spain was 9,6/1000, ranged per AC from 1/1000 in Melilla to 26.6/1000 in La Rioja, with no correlation between case fatality and prevalence of infection. The TL was higher in men (10.2/1000, ratio 1.17 with respect to women), except in Cataluña (ratio 0.92), and especially high in those over 64years of age in La Rioja (143.5/1000), Asturias (69.2/1000) and Basque Country (46.6/1000). Overall excess REL was found to be over 30% in La Rioja (2.91; 95%CI: 2.36-3.57), Asturias (1.51; 95%CI: 1.27-1.80), Basque Country (1.42; 95%CI: 1.31-1.54) and Extremadura (1.37; 95%CI: 1.20-1.57) and in those over 64 years in Madrid and the Canary Islands. SARs-CoV-2 virus infection has been very unevenly distributed in the different ACs, with notably differences in TL between ACs, particularly high in La Rioja, Asturias and the Basque Country. Is important to study the excess in TL the population over 64years of age in the ACs of Madrid and the Canary Islands.
Identifiants
pubmed: 32709574
pii: S1138-3593(20)30205-7
doi: 10.1016/j.semerg.2020.06.013
pmc: PMC7328631
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
spa
Sous-ensembles de citation
IM
Pagination
12-19Informations de copyright
Copyright © 2020. Publicado por Elsevier España, S.L.U.
Références
JMIR Public Health Surveill. 2020 Apr 24;6(2):e19218
pubmed: 32301734
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Int J Infect Dis. 2020 Jul;96:477-481
pubmed: 32470605
Stroke. 2020 Jul;51(7):1991-1995
pubmed: 32438895
Lancet. 2020 May 30;395(10238):1715-1725
pubmed: 32405103
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
Diabetes Metab Syndr. 2020 May - Jun;14(3):251-254
pubmed: 32247213
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Int J Antimicrob Agents. 2020 Apr;55(4):105946
pubmed: 32199877
Geroscience. 2020 Apr;42(2):505-514
pubmed: 32274617
Acta Biomed. 2020 Apr 10;91(3-S):175-179
pubmed: 32275287
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Diagnostics (Basel). 2020 May 19;10(5):
pubmed: 32438677